menu
    • menu

    Digital content for ACS DOBFAR SPA

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a privately held Italian company founded in 1973. We are a fully integrated manufacturer of Cephalosporin, Carbapenem and Penicillin APIs as well as Finished Dosage Formulations (Solid and Injectable). We export our products to MORE than 100 countries all over the world. Our production sites, most of them regularly inspected by EUROPEN AND USA AUTHORITIES (FDA), have strict Quality Standards and our R&D Know-how ma...
    We are a privately held Italian company founded in 1973. We are a fully integrated manufacturer of Cephalosporin, Carbapenem and Penicillin APIs as well as Finished Dosage Formulations (Solid and Injectable). We export our products to MORE than 100 countries all over the world. Our production sites, most of them regularly inspected by EUROPEN AND USA AUTHORITIES (FDA), have strict Quality Standards and our R&D Know-how make us a leading company. Our Commitment: to work in the present while concentrating on the future, because on markets where research and technology are factors of primary importance.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ACS DOBFAR SPAItaly Flag
    Country
    Country
    Italy
    Address
    Address
    Viale Addetta 4/12 20067 Tribiano (Milan)
    Telephone
    Telephone
    +39-029-069-31
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.acsdobfar.it/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    CPhI Worldwide, Milan

    CPhI Worldwide, Milan

    Not Confirmed

    envelop Contact Supplier

    CPhI Worldwide, Milan

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    "ICE is pioneering sustainability, innovation in bile acid research for neurodegenerative diseases”

    "ICE is pioneering sustainability, innovation in bile acid research for neurodegenerative diseases”

    This week, SpeakPharma interviews Roger Viney, Chief Commercial Officer of ICE Pharma, a world-leading manufacturer of specialty biliary acid products with a focus on innovation, environmental responsibility, and a strong company culture. Viney discusses the company’s ambitious sustainability targets, and its exciting research into bile acids’ potential in treating neurodegenerative diseases like Parkinson’s.  🔑 HIGHLIGHTS// focus on innovation, environmental responsibility, and a strong company culture ICE Pharma has set four strategic pillars to guide its sustainability efforts. Can you tell us what these four pillars are and how they contribute to the long-term resilience of the business and its supply chain? In 2022, we developed a comprehensive long-term sustainability strategy, accompanied by a short-term roadmap to guide our actions over the next three years. This outlines the strategic choices that will define our way forward and details the progress we are making against our roadmap. Our sustainability strategy is designed to bolster the long-term resilience of our business and supply chain, provide a source of fulfillment for our employees and enable our customers to continue developing and delivering treatments for hepatic and neurological diseases, as well as other conditions that respond to bile acid-based therapies. By contributing holistically to a healthier society and environment, our strategy aims to create long-term value. We aim to maximize our positive impact on health by opening our Biliary Acid Library of potential new molecules to further the development of these treatments. Additionally, we strive to reduce our environmental footprint by creating products with fewer raw materials, diversifying the animal sources we use, and exploring new plant-based bile acid derivatives. We have established clear targets along four strategic pillars, supported by robust ESG governance and leadership. Firstly, we are committed to fighting illness through product innovation. By providing innovative, safe, and high-quality pharmaceutical ingredients, we help our customers build a healthier society. Secondly, we focus on accelerating sustainable operations by monitoring and reducing our emissions, energy, and water consumption through robust ESG processes and accountability. Thirdly, we prioritize building strong relationships by managing our supply chain transparently, fostering strong supplier relationships, and adhering to responsible business practices. Lastly, we are dedicated to caring for people by cultivating a transformational and inclusive culture that ensures the well-being and development of our employees. 🔑 HIGHLIGHTS// Biliary Acid Library of potential new molecules / robust ESG governance and leadership / manage our supply chain transparently ICE Pharma has committed to an ambitious sustainability plan. Can you elaborate on specific targets it has set to reduce greenhouse gas (GHG) emissions and increase the use of renewable energy? Also, what significant investments have ICE made or plans to make to support these goals? ICE’s carbon footprint aligns with industry standards in the pharmaceutical and API sectors in terms of GHG emissions. We have set an internal target that is challenging yet achievable and aligned with our business objectives – a 20 percent reduction in Scope 1 and 2 emissions (majorly energy-related) and a 30 percent reduction in Scope 3 emissions (from solvents, reagents, and animal byproducts used as raw materials) by 2033. We plan to achieve these targets through two main approaches. For electric power, we aim to achieve 100 percent renewable energy utilization by 2030, and we are well on track to achieve this. We are heavily investing in renewable sources, either through sourcing green energy or through in-house investments in photovoltaic (PV) systems at our factories. Fortunately, the significant growth in installed renewable capacity across all geographies where we operate makes this goal both achievable and financially sustainable. However, a substantial portion of our energy consumption comes from generating heat involved in our processes. To counter this, we are focusing on energy efficiency, targeting over 90 percent of our energy consumption to be covered by ISO 50001 standards, and investing heavily in more efficient technologies. For Scope 3 emissions, our efforts are concentrated on further developing our processes to reduce the amount of chemicals used, improve our yields, and switch to animal-source raw materials with a smaller carbon footprint. 🔑 HIGHLIGHTS// internal target that is challenging yet achievable / 100 percent renewable energy utilization by 2030 ICE Pharma highlights its strong company culture as one of the secrets to its success. Can you speak on how you foster a collaborative and respectful work environment, and how these efforts contribute to the company’s overall success? At ICE Pharma, we place great emphasis on building a collaborative and respectful work environment, recognizing it as a key driver of innovation and success. Our culture is fostered by our Cultural Pillars: Unity, Evolution, and Achievement. These pillars shape our approach in several key areas. Firstly, we value diversity and inclusion. Operating across different cultural contexts and geographies, we have gathered a diverse range of ethnicities. We actively ensure that all voices are represented. This promotes a culture where everyone is respected for their unique perspectives. Secondly, recognizing employee contributions is fundamental to our approach. ICE Pharma celebrates achievements and milestones, ensuring that employees feel valued. We also support professional development and personal growth of employees through initiatives such as secondments and international mentoring programs, and financial support for excellence training courses. This creates motivation and loyalty, reinforcing a positive company atmosphere. Thirdly, we understand the importance of work-life balance. We promote policies that allow employees to maintain a healthy equilibrium between their professional and personal lives, with a special focus on parenthood. This respect for individual well-being translates into a happier, more engaged workforce. By fostering these values, we create a work environment that drives productivity, encourages innovation, and strengthens the company’s overall success. 🔑 HIGHLIGHTS// value diversity and inclusion / recognize employee contributions / understand the importance of work-life balance Considering the unique properties of bile acids, can you discuss how ICE Pharma is leveraging its technology to develop innovative drug delivery systems for emerging therapies or to address challenges with existing medications? We are thrilled about the expanding role of bile acids in medicine. ICE Pharma holds a unique position, being deeply involved in fundamental research, developing new bile acids, bringing them into clinical trials, and manufacturing generic medicines based on these compounds. Recent research has highlighted the role of bile acids as metabolic regulators, revealing their potential to treat a variety of diseases. They have emerged as an excellent class of molecules for targeting metabolic conditions such as type 2 diabetes, obesity, and non-alcoholic fatty liver disease (NAFLD). Bile acids are now known to act on several nuclear receptors, and it is becoming clear that their signaling properties are complex and extend beyond the FXR and TGR5 receptors, where most current research is focused. One particularly exciting area of interest is the potential of bile acids in treating neurodegenerative diseases. In collaboration with the Ferrier Institute, we have contributed to research on Parkinson’s disease. Mitochondrial dysfunction is a well-documented mechanism in both sporadic and familial Parkinson’s disease. Ursodeoxycholic acid (UDCA) has been identified as a bile acid that enhances mitochondrial function in multiple in vitro and in vivo models of Parkinson’s disease. Our studies indicate that modified novel bile acid molecules could lead to the development of more efficacious treatments that improve mitochondrial function and overall cellular health, presenting promising new therapeutic options for Parkinson’s disease. 🔑 HIGHLIGHTS// potential of bile acids in treating neurodegenerative diseases / contributed to research on Parkinson’s disease / present promising new therapeutic options Given ICE Pharma’s commitment to the highest quality and regulatory compliance standards, can you elaborate on how the company ensures that these standards are consistently maintained, especially when dealing with the complexities of animal-derived products? At ICE, we place great emphasis on controlling pathogens in our animal-derived products, ensuring safety and quality throughout the entire supply chain, from the collection of bile to the finished product. The bile is sourced exclusively from authorized countries, and each production batch is meticulously traced to certify that every animal has been raised and sacrificed according to specific guidelines. The initial step in bile processing involves a treatment that certifies the product as TSE/BSE Free. This is followed by at least two additional stages, based on experimental studies conducted by specialized laboratories, which are effective in inactivating viruses. Intermediates and the final product are handled in closed cycles or in contamination-controlled areas (ISO-8 cleanrooms). Beyond these fundamental aspects, ICE is deeply committed to keeping its dossiers up to date with the latest guidelines and constantly monitoring trends in analytical data to ensure consistent product quality. Where possible, we enhance this quality through a change control plan carefully managed by our Quality Assurance team. Staff training, predictive and preventive maintenance plans, equipment qualification, and process validation are crucial activities involving the entire workforce with the support of the Quality Unit. Our commitment to continuous improvement drives us to focus on digital globalization to ensure ever-greater transparency and reliability in the data that supports our work. As John Ruskin said, “quality is never an accident. It is always the result of intelligent effort.” We continue to follow this philosophy in our daily commitment. 🔑 HIGHLIGHTS// bile is sourced exclusively from authorized countries / each production batch is meticulously traced / ensure ever-greater transparency and reliability

    Impressions: 84

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases

    #SpeakPharma With ICE Pharma
    30 Sep 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    The US is in the midst of yet another, or perhaps the most, polarizing Presidential election. The two candidates have highly divergent personas, records, visions and views. That gets reflected in their starkly different visions for the healthcare system.Healthcare is the second most important issue for voters in the 2024 US elections, with only the economy ranking higher, according to the Pew Research Center.In this week’s PharmaFlow, we look at the past approaches of both the contenders — Democratic presidential nominee Kamala Harris and Republican contender Donald Trump — towards healthcare, and what the two presidencies could mean for the US healthcare industry.Both Harris and Trump have a rare point of agreement — that the US government should act on reducing high drug prices. But have they spelt out how they will make healthcare more accessible? Our analysis should give you some answers.Abortion remains a pivotal issue, may shape broader discussions on healthcareTrump takes pride in the fact that he played an important role in overturning Roe v. Wade, a ruling that protected the abortion rights of women across America. Trump did that by selecting Supreme Court justices who were instrumental in overturning it. Two and a half years after Roe v. Wade was overturned, Trump faces an electorate that largely seems to favor abortion rights — according to Pew Research, 63 percent respondents say abortion should be legal in all or most cases, while 36 percent say it should be illegal in all or most cases.Candidates’ stances on abortion access, including the regulation on medications like mifepristone, are being scrutinized by both supporters and opponents of abortion rights. In June this year, the US Supreme Court had unanimously rejected a case to restrict access to the abortion drug mifepristone. The demand for its ban had been raised by an anti-abortion group in Texas.Of late, there have been reports of Republicans trying to distance themselves from aggressive anti-abortion ideas coming from its party men and allies. Aiming to carve-out a political middle ground, Trump has said that abortion policy should be made by the states. Despite Trump’s softening of stance, abortion rights is likely to not only affect voter turnout, but also shape broader discussions on healthcare and women’s rights.Affordable Care Act: Harris to strengthen it, Trump has ‘concepts of a plan’ to replace itHarris has been all for expanding and strengthening the Affordable Care Act (ACA). She has promised to “make affordable healthcare a right, not a privilege.”Trump, on the other hand, had made attempts during his presidency to repeal and replace the ACA, arguing that it provided “lousy healthcare.” While those efforts ultimately failed in the Senate, Trump succeeded in weakening the ACA by eliminating the individual mandate penalty through the 2017 Tax Cuts and Jobs Act.In a potential second term, Trump might renew efforts to dismantle or significantly alter the ACA. Although he has not presented a comprehensive replacement plan, he said during the Presidential debate held on September 9 that he has “concepts of a plan.”Drug prices: Harris to accelerate Medicare price cuts; Trump to focus on genericsHarris has had an aggressive stance on reducing prescription drug costs. Her tie-breaking vote on the Inflation Reduction Act gave Medicare the power to negotiate lower drug prices with pharmaceutical companies.Harris has pledged to accelerate those negotiations, once she becomes President, to cover more drugs and further lower prices for Americans. She also intends to extend the US$ 35 cap on insulin and the US$ 2,000 cap on out-of-pocket spending for seniors to all Americans, not just those on Medicare.Harris plans to make permanent the Biden-Harris tax credit enhancements that have already lowered healthcare premiums by an average of about US$ 800 a year for millions of Americans. This move would ensure continued accessibility to health insurance for a broader segment of the population.However, her stance on insurance companies and Big Pharma, including her support for “march-in” rights, might face resistance from pharmaceutical companies concerned about maintaining incentives for innovation.On the issue of drug pricing, Trump’s record is mixed. While he took credit for some decreases in prescription drug prices during his presidency, his administration’s most significant regulatory changes often favored pharmaceutical companies.Trump did issue a rule setting up a path to import drugs from Canada and other countries, but this initiative has faced significant hurdles, including pushback from Canadian authorities.Trump’s stance on drug pricing for a potential second term appears to focus on increasing generic and biosimilar competition, importing drugs made in the US but sold overseas back to the US, and capping out-of-pocket insulin costs. While he has criticized Big Pharma for putting profits above people, his administration’s policies had often aligned with industry interests.Harris appears committed to drug control; Trump had cut public health fundsMental health and substance abuse are the other areas where Harris has shown strong commitment. Having prosecuted drug traffickers, she has demonstrated her commitment to curbing the opioid epidemic.In the White House, she helped direct more than US$ 150 billion to disrupt the flow of illicit drugs and delivered billions of dollars in investments to states to fund lifesaving programs. Under a Harris administration, we might see increased funding for addiction treatment programs and continued efforts to make overdose-reversal drugs like naloxone more accessible.During his presidency, Trump had significantly reduced funding for public health programs. His administration had suggested budget cuts to the Centers for Disease Control and Prevention (CDC) and other public health agencies, justifying them as measures for fiscal responsibility.Our viewGiven her record, a Harris presidency could lead to increased insurance coverage. However, it might also come with increased regulation and price controls. More aggressive drug price negotiations could pressure pharmaceutical companies’ profit margins, potentially affecting R&D budgets. Stricter vigilance on the pharmaceutical industry could lead to more litigation and regulatory challenges for drug companies. But in the long run, this might also improve public trust in drug companies and in the healthcare systems.Under a second Trump term, reduced public health funding could create challenges for community health providers and public health initiatives. An emphasis on generic competition could pressure brand-name drug manufacturers, but create opportunities for generic drug makers.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 700

    https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices

    #Phispers by PHARMACOMPASS
    26 Sep 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Dobfar's Generic Cefepime Hydrochloride Receives Approval in the U.S.
    Dobfar's Generic Cefepime Hydrochloride Receives Approval in the U.S.

    03 Jan 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065441

    FDA
    03 Jan 2022
    Share Share
    ACS Dobfar SPA's Generic Penicillin G Potassium Receives Approval in US
    ACS Dobfar SPA's Generic Penicillin G Potassium Receives Approval in US

    31 Oct 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205043

    FDA
    31 Oct 2018
    Share Share
    Acs Dobfar Generic Ertapenem Sodium Receives Approval In US
    Acs Dobfar Generic Ertapenem Sodium Receives Approval In US

    19 Apr 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208790

    FDA
    19 Apr 2018
    Share Share
    FDA Cites Three Pharma, Five Medical Device Companies
    FDA Cites Three Pharma, Five Medical Device Companies

    01 Feb 2017

    // PHARMA MANUFACTURING

    http://www.pharmamanufacturing.com/industrynews/2017/fda-cites-three-pharma-five-medical-device-companies/

    PHARMA MANUFACTURING
    01 Feb 2017
    Share Share
    FACTA Farmaceutici Receives FDA Warning Letter
    FACTA Farmaceutici Receives FDA Warning Letter

    13 Jan 2017

    // FDA

    https://www.pharmacompass.com/pdf/news/facta-farmaceutici-receives-fda-warning-letter-1485923976.pdf

    FDA
    13 Jan 2017
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Ampicillin Sodium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Formnext Forum
    Not Confirmed
    arrow

    Ampicillin Sodium

    Italy

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Formnext Forum
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 13661

    Submission : 1998-09-01

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2004-303 - Rev 03

    Issue Date : 2024-01-24

    Type : Chemical

    Substance Number : 578

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 219MF10051

    Registrant's Address : Viale Addetta, 4/12, 20067 Tribiano (Milan) Italy

    Initial Date of Registration : 2007-02-13

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 52946-0705

    Start Marketing Date : 2009-12-09

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg 1kg/kg)

    Marketing Category : DRUG FOR FURTHER PRO...

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Cefaclor

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Formnext Forum
    Not Confirmed
    arrow

    Cefaclor

    Italy

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Formnext Forum
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 13780

    Submission : 1998-09-01

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2023-429 - Rev 00

    Issue Date : 2024-05-24

    Type : Chemical

    Substance Number : 986

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 218MF10591

    Registrant's Address : Viale Addetta, 4/12, 20067 Tribiano (Milan) Italy

    Initial Date of Registration : 2006-06-22

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 52946-0912

    Start Marketing Date : 2009-12-09

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Kyungbo Pharmaceutical Co., Ltd.

    Registration Date : 2020-05-11

    Registration Number : 20050831-20-A-17-02(20)

    Manufacturer Name : ACS DOBFAR SpA

    Manufacturer Address : Via Marzabotto, 1, 7/9 - 20871 Vimercate (MB), Italy

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Cefazolin Sodium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Formnext Forum
    Not Confirmed
    arrow

    Cefazolin Sodium

    Italy

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Formnext Forum
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 13208

    Submission : 1998-04-30

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1996-083 - Rev 06

    Issue Date : 2019-06-17

    Type : Chemical

    Substance Number : 988

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 222MF10020

    Registrant's Address : Viale Addetta, 4/12, 20067 Tribiano (Milan) Italy

    Initial Date of Registration : 2010-01-22

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 52946-0801

    Start Marketing Date : 2009-12-09

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Sungjin Exim Co., Ltd.

    Registration Date : 2021-04-27

    Registration Number : 20210427-210-J-635

    Manufacturer Name : ACS Dobfar SpA

    Manufacturer Address : Viale Addetta, 2a/12-3/5 20067 Tribiano, Milano, Italy

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Ceftazidime

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Formnext Forum
    Not Confirmed
    arrow

    Ceftazidime

    Italy

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Formnext Forum
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 13683

    Submission : 1998-09-01

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2023-299 - Rev 00

    Issue Date : 2024-07-29

    Type : Chemical

    Substance Number : 1405

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 305MF10039

    Registrant's Address : Viale Addetta, 4/12, 20067 Tribiano (Milan) Italy

    Initial Date of Registration : 2023-03-23

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 52946-0924

    Start Marketing Date : 2019-05-22

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Pfizer Pharmaceuticals Korea Co., Ltd.

    Registration Date : 2022-12-22

    Registration Number : 20221222-210-J-1424

    Manufacturer Name : ACS Dobfar SpA@ACS DOBFAR SpA

    Manufacturer Address : Viale Addetta, 2a/12–3/5, 20067 Tribiano (MI), Italy@Via Marzabotto, 1, 7/9 20871 Vimercate (MB), Italy

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Amikacin Sulfate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Formnext Forum
    Not Confirmed
    arrow

    Amikacin Sulfate

    Italy

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Formnext Forum
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-12-05

    Pay. Date : 2013-07-05

    DMF Number : 13763

    Submission : 1998-09-01

    Status : Active

    Type : II

     CEP/COS JDMF arrow-down
    ✖

    Registration Number : 301MF10052

    Registrant's Address : Viale Addetta, 4/12, 20067 Tribiano (Milan) Italy

    Initial Date of Registration : 2019-08-28

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 52946-0600

    Start Marketing Date : 2009-12-09

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Cefotaxime

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Formnext Forum
    Not Confirmed
    arrow

    Cefotaxime

    Italy

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Formnext Forum
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 14367

    Submission : 1999-08-25

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1998-050 - Rev 03

    Issue Date : 2008-02-28

    Type : Chemical

    Substance Number : 989

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 52946-0826

    Start Marketing Date : 2009-12-09

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Ceftriaxone

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Formnext Forum
    Not Confirmed
    arrow

    Ceftriaxone

    Italy

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Formnext Forum
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 17259

    Submission : 2004-03-25

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2003-169 - Rev 01

    Issue Date : 2011-02-18

    Type : Chemical

    Substance Number : 991

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 52946-0827

    Start Marketing Date : 2009-12-09

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Cefuroxime Sodium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Formnext Forum
    Not Confirmed
    arrow

    Cefuroxime Sodium

    Italy

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Formnext Forum
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 13205

    Submission : 1998-04-30

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1996-007 - Rev 05

    Issue Date : 2022-07-25

    Type : Chemical

    Substance Number : 992

    Status : Valid

     JDMF EU-WC NDC arrow-down
    ✖

    NDC Package Code : 52946-0905

    Start Marketing Date : 2009-12-09

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Cephalexin Monohydrate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Formnext Forum
    Not Confirmed
    arrow

    Cephalexin Monohydrate

    Italy

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Formnext Forum
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 13588

    Submission : 1998-09-01

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 1996-099 - Rev 04

    Issue Date : 2023-12-06

    Type : Chemical

    Substance Number : 708

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Cephalexin Monohydrate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    Formnext Forum
    Not Confirmed
    arrow

    Cephalexin Monohydrate

    Italy

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    Formnext Forum
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2017-03-17

    Pay. Date : 2017-02-27

    DMF Number : 13612

    Submission : 1998-09-01

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1997-128 - Rev 03

    Issue Date : 2019-08-16

    Type : Chemical

    Substance Number : 708

    Status : Valid

     JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    USDMF

    read-more
    read-more

    01

    17a-hydroxyprogesterone Caproate Usp...

    Italy
    Luxepack
    Not Confirmed
    arrow

    02

    17a-hydroxyprogesterone, Bulk

    Italy
    Luxepack
    Not Confirmed
    arrow

    03

    6-alpha-methylprednisolone-21-hydrog...

    Italy
    Luxepack
    Not Confirmed
    arrow

    04

    6-amino Penicillanic Acid

    Italy
    Luxepack
    Not Confirmed
    arrow

    05

    6-aminopenicillanic Acid (6-apa)

    Italy
    Luxepack
    Not Confirmed
    arrow

    06

    7-adca (7-amino-3-desacetoxy Cephalo...

    Italy
    Luxepack
    Not Confirmed
    arrow

    07

    7-amino-deacetoxy-cephalosporanic Ac...

    Italy
    Luxepack
    Not Confirmed
    arrow

    08

    7-zaca- 7-amino-3-[2-(5-metbyl-1,3,4...

    Italy
    Luxepack
    Not Confirmed
    arrow

    09

    Acid Cefazolin (intermediate Grade)

    Italy
    Luxepack
    Not Confirmed
    arrow

    10

    Acid Cefotetan

    Italy
    Luxepack
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    CEP/COS

    read-more
    read-more

    01

    Amoxicillin sodium, Sterile

    CEP/COS

    Discovery on Target
    Not Confirmed
    arrow

    02

    Ampicillin sodium, Sterile and bacterial...

    CEP/COS

    Discovery on Target
    Not Confirmed
    arrow

    03

    Cefaclor

    CEP/COS

    Discovery on Target
    Not Confirmed
    arrow

    04

    Cefaclor, Enzymatic

    CEP/COS

    Discovery on Target
    Not Confirmed
    arrow

    05

    Cefadroxil monohydrate, Powder, compacte...

    CEP/COS

    Discovery on Target
    Not Confirmed
    arrow

    06

    Cefalexin monohydrate

    CEP/COS

    Discovery on Target
    Not Confirmed
    arrow

    07

    Cefalexin monohydrate, (Enzymatic proces...

    CEP/COS

    Discovery on Target
    Not Confirmed
    arrow

    08

    Cefazolin sodium, Sterile

    CEP/COS

    Discovery on Target
    Not Confirmed
    arrow

    09

    Cefepime dihydrochloride monohydrate, St...

    CEP/COS

    Discovery on Target
    Not Confirmed
    arrow

    10

    Cefotaxime sodium, Sterile

    CEP/COS

    Discovery on Target
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact ACS DOBFAR SPA and get a quotation

    ACS DOBFAR SPA is a supplier offers 133 products (APIs, Excipients or Intermediates).

    Find a price of Ampicillin Sodium bulk with DMF, CEP, JDMF offered by ACS DOBFAR SPA

    Find a price of Cefaclor bulk with DMF, CEP, JDMF offered by ACS DOBFAR SPA

    Find a price of Cefazolin Sodium bulk with DMF, CEP, JDMF offered by ACS DOBFAR SPA

    Find a price of Ceftazidime bulk with DMF, CEP, JDMF offered by ACS DOBFAR SPA

    Find a price of Amikacin Sulfate bulk with DMF, JDMF offered by ACS DOBFAR SPA

    Find a price of Cefaclor bulk with CEP, JDMF offered by ACS DOBFAR SPA

    Find a price of Cefepime bulk with DMF, CEP offered by ACS DOBFAR SPA

    Find a price of Cefotaxime bulk with DMF, CEP offered by ACS DOBFAR SPA

    Find a price of Ceftriaxone bulk with DMF, CEP offered by ACS DOBFAR SPA

    Find a price of Cefuroxime Sodium bulk with DMF, CEP offered by ACS DOBFAR SPA

    Find a price of Cephalexin Monohydrate bulk with DMF, CEP offered by ACS DOBFAR SPA

    Find a price of Cilastatin Sodium bulk with DMF, JDMF offered by ACS DOBFAR SPA

    Find a price of Clindamycin Phosphate bulk with DMF, CEP offered by ACS DOBFAR SPA

    Find a price of Meropenem bulk with DMF, CEP offered by ACS DOBFAR SPA

    Find a price of Sulbactam Sodium bulk with DMF, JDMF offered by ACS DOBFAR SPA

    Find a price of Clindamycin Hydrochloride bulk with CEP offered by ACS DOBFAR SPA

    Find a price of 6-Aminopenicillanic Acid bulk with DMF offered by ACS DOBFAR SPA

    Find a price of 7-Amino-3-[(5-Methyl-1,3,4-Thiadiazol-2-Yl)Thiomethyl]Cephalosphoranic Acid bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Amikacin bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Amoxicillin Sodium bulk with CEP offered by ACS DOBFAR SPA

    Find a price of Amoxicillin Trihydrate bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Ampicillin Sodium bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Ampicillin Trihydrate bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Carbopol 940 API bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Cefadroxil bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Cefadroxil Monohydrate bulk with CEP offered by ACS DOBFAR SPA

    Find a price of Cefalotin sodium Sterile bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Cefazolin bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Cefepime Hydrochloride bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Cefotaxime bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Cefotetan bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Cefotetan Disodium bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Cefoxitin bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Cefoxitin Sodium bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Ceftaroline Fosamil bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Ceftazidime bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Cefuroxime Axetil bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Cephalexin bulk with JDMF offered by ACS DOBFAR SPA

    Find a price of Cephapirin bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Cephapirin Sodium bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Ertapenem Sodium bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Gentamicin Sulfate bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Imipenem bulk with DMF offered by ACS DOBFAR SPA

    Find a price of L-Arginine bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Meropenem bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Mono Propylene Glycol bulk with JDMF offered by ACS DOBFAR SPA

    Find a price of Nafcillin Sodium bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Penicillin G Potassium bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Piperacillin + Tazobactam bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Sodium Bicarbonate bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Sodium Carbonate bulk with DMF offered by ACS DOBFAR SPA

    Find a price of Trisodium Citrate Dihydrate bulk with DMF offered by ACS DOBFAR SPA

    Find a price of DEFU (DECARBAMOYLCEFUROXINE) bulk with DMF offered by ACS DOBFAR SPA

    Find a price of 6-Aminopenicillanic Acid bulk offered by ACS DOBFAR SPA

    Find a price of 7-Aminodesacetoxycephalosporanic Acid bulk offered by ACS DOBFAR SPA

    Find a price of Amikacin Sulfate bulk offered by ACS DOBFAR SPA

    Find a price of Beclomethasone Dipropionate bulk offered by ACS DOBFAR SPA

    Find a price of Benzyl Penicillin bulk offered by ACS DOBFAR SPA

    Find a price of Betamethasone bulk offered by ACS DOBFAR SPA

    Find a price of Betamethasone Sodium Phosphate bulk offered by ACS DOBFAR SPA

    Find a price of Betamethasone Valerate bulk offered by ACS DOBFAR SPA

    Find a price of Bombesin Tyr4 bulk offered by ACS DOBFAR SPA

    Find a price of Cabergoline bulk offered by ACS DOBFAR SPA

    Find a price of Carbopol 940 API bulk offered by ACS DOBFAR SPA

    Find a price of Cefadroxil bulk offered by ACS DOBFAR SPA

    Find a price of Cefalotin sodium Sterile bulk offered by ACS DOBFAR SPA

    Find a price of Cefamandole Nafate bulk offered by ACS DOBFAR SPA

    Find a price of Cefazolin bulk offered by ACS DOBFAR SPA

    Find a price of Cefazolin Sodium bulk offered by ACS DOBFAR SPA

    Find a price of Cefoxitin Sodium bulk offered by ACS DOBFAR SPA

    Find a price of Cefprozil bulk offered by ACS DOBFAR SPA

    Find a price of Ceftriaxone bulk offered by ACS DOBFAR SPA

    Find a price of Cephradine bulk offered by ACS DOBFAR SPA

    Find a price of Clindamycin Phosphate bulk offered by ACS DOBFAR SPA

    Find a price of Cloxacillin Sodium bulk offered by ACS DOBFAR SPA

    Find a price of Desonide bulk offered by ACS DOBFAR SPA

    Find a price of Dexamethasone bulk offered by ACS DOBFAR SPA

    Find a price of Dexamethasone Sodium Phosphate bulk offered by ACS DOBFAR SPA

    Find a price of Disodium Hydrogen Phosphate bulk offered by ACS DOBFAR SPA

    Find a price of Endrysone bulk offered by ACS DOBFAR SPA

    Find a price of Ethanol bulk offered by ACS DOBFAR SPA

    Find a price of Flucloxacillin Sodium bulk offered by ACS DOBFAR SPA

    Find a price of Flumethasone bulk offered by ACS DOBFAR SPA

    Find a price of Flumethasone Pivalate bulk offered by ACS DOBFAR SPA

    Find a price of Fluocinolone Acetonide bulk offered by ACS DOBFAR SPA

    Find a price of Fluocinonide bulk offered by ACS DOBFAR SPA

    Find a price of Fluorometholone bulk offered by ACS DOBFAR SPA

    Find a price of Fluorometholone Acetate bulk offered by ACS DOBFAR SPA

    Find a price of Flurandrenolone bulk offered by ACS DOBFAR SPA

    Find a price of Hydrocortisone Sodium Succinate bulk offered by ACS DOBFAR SPA

    Find a price of Hydroxyprogesterone Caproate bulk offered by ACS DOBFAR SPA

    Find a price of Ibuprofen bulk offered by ACS DOBFAR SPA

    Find a price of Medroxyprogesterone Acetate bulk offered by ACS DOBFAR SPA

    Find a price of Medrysone bulk offered by ACS DOBFAR SPA

    Find a price of Methyldopa bulk offered by ACS DOBFAR SPA

    Find a price of Methylprednisolone Acetate bulk offered by ACS DOBFAR SPA

    Find a price of Methylprednisolone Hemisuccinate bulk offered by ACS DOBFAR SPA

    Find a price of Nafcillin Sodium bulk offered by ACS DOBFAR SPA

    Find a price of Oxacillin Sodium bulk offered by ACS DOBFAR SPA

    Find a price of Penicillin G Potassium bulk offered by ACS DOBFAR SPA

    Find a price of Prednisolone Sodium Phosphate bulk offered by ACS DOBFAR SPA

    Find a price of Progesterone bulk offered by ACS DOBFAR SPA

    Find a price of Sodium Carbonate bulk offered by ACS DOBFAR SPA

    Find a price of Spironolactone bulk offered by ACS DOBFAR SPA

    Find a price of Tacrolimus bulk offered by ACS DOBFAR SPA

    Find a price of Tetracycline Phosphate bulk offered by ACS DOBFAR SPA

    Find a price of Triamcinolone bulk offered by ACS DOBFAR SPA

    Find a price of Triamcinolone Acetonide bulk offered by ACS DOBFAR SPA

    Find a price of Triamcinolone Diacetate bulk offered by ACS DOBFAR SPA

    Find a price of Triprolidine Hydrochloride bulk offered by ACS DOBFAR SPA

    Find a price of Vancomycin Hydrochloride bulk offered by ACS DOBFAR SPA

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN RODANO, ITALY. bulk offered by ACS DOBFAR SPA

    Find a price of PERSONNEL, FACILITIES AND GENERAL OPERATING PROCEDURES bulk offered by ACS DOBFAR SPA

    Find a price of MANUFACTURING FACILITIES, PERSONNEL, AND GENERAL OPERATIONS IN BERGAMO, ITALY bulk offered by ACS DOBFAR SPA

    Find a price of THYMIC HUMORAL FACTOR GAMMA 2 ACTIVE DRUG SUBS. - MILAN,ITALY bulk offered by ACS DOBFAR SPA

    Find a price of FACILITIES AND CONTROLS bulk offered by ACS DOBFAR SPA

    Find a price of FACILITY AND OPERATING PROCEDURES IN VIA MARZABOTTO, VIMERCATE, MILANO, ITALY (PREVIOUSLY AN ANTIBIOTIC FILE) bulk offered by ACS DOBFAR SPA

    Find a price of O-FORMYL CEFAMANDOLE ACETONITRILE SOLVATE bulk offered by ACS DOBFAR SPA

    Find a price of CHEM. & PHARMACY OF ANTIBIOTIC LM 427 AS IT WILL BE REFERENCED BY INDS bulk offered by ACS DOBFAR SPA

    Find a price of CEFUROXIME bulk offered by ACS DOBFAR SPA

    Find a price of THYMIC HUMORAL FACTOR GAMMA 2 FINISHED DOSAGE, MILAN ITALY bulk offered by ACS DOBFAR SPA

    Find a price of Amphotericin B bulk offered by ACS DOBFAR SPA

    Find a price of Ampicillin bulk offered by ACS DOBFAR SPA

    Find a price of Biapenem bulk offered by ACS DOBFAR SPA

    Find a price of Cefixime bulk offered by ACS DOBFAR SPA

    Find a price of Cefoperazone Sodium bulk offered by ACS DOBFAR SPA

    Find a price of Cephapirin Benzathine bulk offered by ACS DOBFAR SPA

    Find a price of Cephradine Monohydrate bulk offered by ACS DOBFAR SPA

    Find a price of Cloxacillin Benzathine bulk offered by ACS DOBFAR SPA

    Find a price of Doripenem bulk offered by ACS DOBFAR SPA

    Find a price of Nafcillin bulk offered by ACS DOBFAR SPA

    Find a price of Piperacillin Sodium bulk offered by ACS DOBFAR SPA

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search